Myrikson Sustained Release Tablet (Eperisone Hydrochloride)

Adult dose

This medication is a sustained release tablet, and it should be taken whole without crushing, splitting, or chewing. Adults should take 1 tablet (75mg of eperisone hydrochloride) twice a day after meals. Dosage may be adjusted according to age and symptoms.

This drug should not be used in patients with hypersensitivity to this medication or in patients with severe myasthenia gravis. Patients with a history of hypersensitivity to the drug or with liver function problems should use this drug with caution, as liver function may deteriorate. Allergic reactions such as redness, itching, hives, swelling, and dyspnea may rarely occur, and if these symptoms appear, use should be discontinued immediately and appropriate treatment should be received. Additionally, serious skin adverse reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome may occur, so symptoms such as fever, skin rash, blisters, itching, conjunctival hyperemia, and stomatitis should be carefully monitored, and if any of these symptoms occur, the use of the medication should be discontinued immediately. Various adverse reactions such as abnormalities in liver or kidney function, anemia, insomnia, drowsiness, headaches, indigestion, nausea, vomiting, constipation, diarrhea, urinary retention, may occur occasionally, so the body's condition should be observed carefully. During treatment with this drug, symptoms such as weakness, staggering, and drowsiness may appear, so if these symptoms occur, it is advisable to reduce the dosage or discontinue use. Drowsiness or decreased attention may occur, so it is safe to avoid driving or operating dangerous machinery. Pregnant women or those who may become pregnant should only use this medication when the benefit of treatment outweighs the risks, as its safety has not been established. Breastfeeding women should avoid use if possible, and if unavoidable, breastfeeding should be discontinued. In children, safety has not been fully established, so caution is required in use. Elderly patients may have decreased physical function, so careful attention to dosage adjustment is needed.

Serious side effects

Hives, swelling, dyspnea, shock and anaphylactic reactions, toxic epidermal necrolysis (Lyell's syndrome), mucosal epidermal necrolysis (Stevens-Johnson syndrome), fever, erythema, blisters, conjunctival hyperemia, stomatitis, anaphylactic reactions, angioedema

Mild side effects

• Headache
• drowsiness
• insomnia
• dizziness
• nausea
• vomiting
• loss of appetite
• stomach discomfort
• dry mouth
• constipation

This medication should be stored in a sealed container to protect it from air and moisture. It is best to keep it at room temperature between 1 to 30 degrees Celsius. This helps maintain the drug's efficacy and safety for a long time.

Appearance

White to nearly white round sustained release film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle